Sort   by:  
 Page size 
UnknownNASHmap: clinical utility of a machine learning model to identify patients at risk of NASH in real-world settings.
Not available
S-EPMC10076319 | biostudies-literature
UnknownClinical utility of the Fibrosis-4 index for predicting mortality in patients with heart failure with or without metabolic dysfunction-associated steatotic liver disease: a prospective cohort study.
Not available
S-EPMC11648889 | biostudies-literature
UnknownWeight Change is Associated With Metabolic Liver Health in a General Population Extending Beyond Weight Loss Targets of International Guidelines.
Not available
S-EPMC12670896 | biostudies-literature
UnknownImpairment of health-related quality of life among people with type 2 diabetes and advanced liver fibrosis.
Not available
S-EPMC11408596 | biostudies-literature
UnknownOutcome Prediction of Covert Hepatic Encephalopathy in Liver Cirrhosis: Comparison of Four Testing Strategies.
Not available
S-EPMC7339190 | biostudies-literature
UnknownAssessment of psychological resilience in a large cohort of the general population: Validation and norm values of the RS-5.
Not available
S-EPMC11469496 | biostudies-literature
UnknownEvaluation of IL-6 for Stepwise Diagnosis of Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis.
Not available
S-EPMC9035565 | biostudies-literature
UnknownDevelopment of a novel machine learning model to predict presence of nonalcoholic steatohepatitis.
Not available
S-EPMC8200272 | biostudies-literature
UnknownCombined effects of the PNPLA3 rs738409, TM6SF2 rs58542926, and MBOAT7 rs641738 variants on NAFLD severity: a multicenter biopsy-based study.
Not available
S-EPMC5234727 | biostudies-literature
UnknownInflammation in liver fibrosis and atrial fibrillation: A prospective population-based proteomic study.
Not available
S-EPMC11460462 | biostudies-literature
Sort   by:  
 Page size